医療におけるバイオミメティクスの世界市場規模、シェア、産業動向分析レポート：疾患タイプ別、用途別（創傷治癒、組織工学、ドラッグデリバリー、その他）、地域別展望と予測、2023年～2029年

医療におけるバイオミメティクス市場規模は、2029年には577億米ドルに達し、予測期間中にCAGR6.9%の市場成長率で上昇すると予測されています。

バイオミメティクス、バイオミミクリー、またはバイオミメティクスの応用とトランスレーショナルな人間への応用のために、刺激的な自然システムの機能と構造の間の基礎メカニズムと接続を解明することは、単一の個人またはグループとして、健康なエンドユーザー/消費者や治療が必要な患者を問わず、同様のペイシェントジャーニーが招待されています。バイオミメティクスは、化学、工学、生物学の原理を利用して、生物学的プロセスを模倣した材料、機械、または合成システムを作成する学際的な分野です。

バイオミメティクスに基づく設計は、ドラッグデリバリー、再生医療、組織工学への応用が期待されています。また、薬学や医学の分野でもバイオミメティクスを活用することで、がんなどの生命を脅かす病気への対処に大きな可能性を示しています。医療におけるバイオミメティクス市場の急拡大は、バイオミメティクス研究への政府投資の増加、ヘルスケア分野における医療工学とナノテクノロジーの統合と進歩が主な要因となっています。

COVID-19の影響分析

検疫の緩和、ワクチン接種の利点、COVID-19患者の減少により、企業は製品の需要を満たすために手続きを再開しています。検疫やパンデミックのシナリオは、多くの国で改善されつつあり、明らかに回復傾向にあります。いくつかの開業医は、地域や国際的な指導を実践することでサービスを開始しています。さらに、医療におけるバイオミメティクスの販売増加、バイオミメティック製品の技術進歩、疾病の負担を軽減するための政府の取り組み、規制当局の承認などにより、予測期間中に医療におけるバイオミメティクスの市場シェアが増加しました。したがって、これらの動向は市場を安定させ、予測期間中に成長を引き起こすと予想されます。

市場成長要因

絶え間ない高齢化により、バイオミメティクスの需要が高まる

高齢化社会の進展は、新興国に影響を与える最も重要な懸念事項の一つです。また、心臓病、末梢動脈疾患、静脈血栓塞栓症などの高齢者の慢性疾患の蔓延により、医療におけるバイオミメティクスの需要と採用が増加すると予測されています。米国疾病管理予防センターの調査によると、2020年には男性の27％近く、女性の21％以上が末梢血管疾患を患い、55歳から65歳の19.1％以上が影響を受けるといわれています。高齢化に伴う疾病の増加に加え、患者ケアにおけるバイオミメティクスの用途が拡大した結果、市場の成長を後押しすることになるでしょう。

ナノテクノロジーの市場開拓が市場成長を支える

ナノテクノロジーの革新がもたらすドラッグデリバリーシステムの進歩は、予測期間中、医療におけるバイオミメティクススの成長にプラスの影響を与えると考えられます。ナノ材料は生物医学的用途に魅力的であり、その生体適合性、物理的および化学的特性に基づいて、バイオミメティック医療に多大な可能性を示しています。バイオミメティック機能化ナノテクノロジーの開発により、細胞膜から得られる成分によるナノ材料の機能化と修飾が可能になり、安定性、生体適合性、特異性、標的性が改善されたバイオミメティックナノ材料が得られるようになりました。したがって、非侵襲的な疾患診断にバイオミメティック・ナノマテリアルを使用することで、予測期間中の市場成長を促進することができます。

市場抑制要因

医療におけるバイオミメティクスに関連する高コスト

バイオミメティック技術の開発には複雑な製造手順が必要であるため、開発・製造コストが高くなる可能性があります。そのため、価格や利用可能性が低下し、患者が利用しにくくなる可能性があります。また、従来の医薬品やバイオ医薬品を作るのに必要な化学物質を扱うのは、細胞やウイルスベクターを扱うよりもはるかに難しいため、細胞療法や遺伝子療法は非常に高価になっています。その結果、薬を投与する患者さんの数は、一般的なバイオ医薬品の場合、数千人、数百万人と倍増することになります。このように、医療におけるバイオミメティクスに関連する高コストが、予想される期間中の市場成長の妨げになると予想されます。

疾患タイプの展望

医療におけるバイオミメティクス市場は、疾患タイプ別に、眼科、循環器、整形外科、歯科、その他に分類されます。心血管セグメントは、2022年の医療におけるバイオミメティクス市場でかなりの成長率を確保しました。これは、年間1,790万人が死亡し、CVDが世界の死因の第一位であるためです。毎年、210万人以上の人々が延命のためにCVDインプラントを装着しています。その他の特典として、予測期間中、このセグメントは、技術的に高度な製品の導入や政府の資金援助によってもたらされる有利な機会から恩恵を受け、医療におけるバイオミメティクスの利用が増加し、それによってセグメントの成長が加速すると考えられます。

用途の展望

医療におけるバイオミメティクス市場は、用途別に創傷治癒、組織工学、ドラッグデリバリー、その他に分類されます。2022年の医療におけるバイオミメティクス市場では、創傷治癒分野が最大の収益シェアを占めています。これは、手術症例の増加や慢性疾患の発生率の上昇により、創傷治癒や創傷ケアを促進する製品への需要が高まっていることに起因しています。教材やバイオミメティクスの進歩により、線維性創傷治癒を再生プロセスへと迂回させることがますます有利になりつつあります。

地域の展望

地域別に見ると、医療におけるバイオミメティクス市場は、北米、欧州、アジア太平洋、LAMEAで分析されています。北米地域は、2022年の医療におけるバイオミメティクス市場において最も高い収益シェアを生み出します。これは、歯科用バイオミメティクス製品を必要とする歯科疾患の増加、バイオミメティクス製品研究に対する政府支援の増加、先進国における資本所得の大幅な増加に起因します。さらに、すでに存在し、支出レベルの低下に努めている高度な償還メカニズムも、市場の拡大に寄与しています。結果として、これらの要素は北米地域における医療におけるバイオミメティクス市場の成長を後押ししています。

目次

第1章 市場範囲と調査手法

• 市場の定義
• 目的
• 市場範囲
• セグメンテーション
• 調査手法

第2章 市場概要

• イントロダクション
  • 概要
    • 市場構成とシナリオ
• 市場に影響を与える主な要因
  • 市場促進要因
  • 市場抑制要因

第3章 医療におけるバイオミメティクス市場で展開される戦略

第4章 世界の医療におけるバイオミメティクス市場：疾患タイプ別

• 世界の歯科市場：地域別
• 世界の整形外科市場：地域別
• 世界の眼科市場：地域別
• 世界の心臓血管市場：地域別
• 世界のその他の市場：地域別

第5章 世界の医療におけるバイオミメティクス市場：用途別

• 世界の創傷治癒市場：地域別
• 世界の組織工学市場：地域別
• 世界のドラッグデリバリー市場：地域別
• 世界のその他の市場：地域別

第6章 世界の医療におけるバイオミメティクス市場：地域別

• 北米
  • 北米の市場：国別
    • 米国
    • カナダ
    • メキシコ
    • その他北米地域
• 欧州
  • 欧州の市場：国別
    • ドイツ
    • 英国
    • フランス
    • ロシア
    • スペイン
    • イタリア
    • その他欧州地域
• アジア太平洋
  • アジア太平洋の市場：国別
    • 中国
    • 日本
    • インド
    • 韓国
    • シンガポール
    • マレーシア
    • その他アジア太平洋地域
• ラテンアメリカ・中東・アフリカ
  • ラテンアメリカ・中東・アフリカの市場：国別
    • ブラジル
    • アルゼンチン
    • アラブ首長国連邦
    • サウジアラビア
    • 南アフリカ
    • ナイジェリア
    • その他ラテンアメリカ・中東・アフリカ地域

第7章 企業プロファイル

• Zimmer Biomet Holdings, Inc
• BioHorizons, Inc（Henry Schein, Inc.）
• SynTouch Inc
• CorNeat Vision Ltd
• Osteopore International Pte Ltd
• Curasan, Inc
• Otsuka Medical Devices Co, Ltd.（Otsuka Holdings Co. Ltd.）
• Swedish Biomimetics 3000 ApS
• Keystone Dental Group
• Blatchford Limited

LIST OF TABLES

• TABLE 1 Global Medical Biomimetics Market, 2019 - 2022, USD Million
• TABLE 2 Global Medical Biomimetics Market, 2023 - 2029, USD Million
• TABLE 3 Global Medical Biomimetics Market by Disease Type, 2019 - 2022, USD Million
• TABLE 4 Global Medical Biomimetics Market by Disease Type, 2023 - 2029, USD Million
• TABLE 5 Global Dental Market by Region, 2019 - 2022, USD Million
• TABLE 6 Global Dental Market by Region, 2023 - 2029, USD Million
• TABLE 7 Global Orthopedic Market by Region, 2019 - 2022, USD Million
• TABLE 8 Global Orthopedic Market by Region, 2023 - 2029, USD Million
• TABLE 9 Global Ophthalmology Market by Region, 2019 - 2022, USD Million
• TABLE 10 Global Ophthalmology Market by Region, 2023 - 2029, USD Million
• TABLE 11 Global Cardiovascular Market by Region, 2019 - 2022, USD Million
• TABLE 12 Global Cardiovascular Market by Region, 2023 - 2029, USD Million
• TABLE 13 Global Others Market by Region, 2019 - 2022, USD Million
• TABLE 14 Global Others Market by Region, 2023 - 2029, USD Million
• TABLE 15 Global Medical Biomimetics Market by Application, 2019 - 2022, USD Million
• TABLE 16 Global Medical Biomimetics Market by Application, 2023 - 2029, USD Million
• TABLE 17 Global Wound Healing Market by Region, 2019 - 2022, USD Million
• TABLE 18 Global Wound Healing Market by Region, 2023 - 2029, USD Million
• TABLE 19 Global Tissue Engineering Market by Region, 2019 - 2022, USD Million
• TABLE 20 Global Tissue Engineering Market by Region, 2023 - 2029, USD Million
• TABLE 21 Global Drug Delivery Market by Region, 2019 - 2022, USD Million
• TABLE 22 Global Drug Delivery Market by Region, 2023 - 2029, USD Million
• TABLE 23 Global Others Market by Region, 2019 - 2022, USD Million
• TABLE 24 Global Others Market by Region, 2023 - 2029, USD Million
• TABLE 25 Global Medical Biomimetics Market by Region, 2019 - 2022, USD Million
• TABLE 26 Global Medical Biomimetics Market by Region, 2023 - 2029, USD Million
• TABLE 27 North America Medical Biomimetics Market, 2019 - 2022, USD Million
• TABLE 28 North America Medical Biomimetics Market, 2023 - 2029, USD Million
• TABLE 29 North America Medical Biomimetics Market by Disease Type, 2019 - 2022, USD Million
• TABLE 30 North America Medical Biomimetics Market by Disease Type, 2023 - 2029, USD Million
• TABLE 31 North America Dental Market by Country, 2019 - 2022, USD Million
• TABLE 32 North America Dental Market by Country, 2023 - 2029, USD Million
• TABLE 33 North America Orthopedic Market by Country, 2019 - 2022, USD Million
• TABLE 34 North America Orthopedic Market by Country, 2023 - 2029, USD Million
• TABLE 35 North America Ophthalmology Market by Country, 2019 - 2022, USD Million
• TABLE 36 North America Ophthalmology Market by Country, 2023 - 2029, USD Million
• TABLE 37 North America Cardiovascular Market by Country, 2019 - 2022, USD Million
• TABLE 38 North America Cardiovascular Market by Country, 2023 - 2029, USD Million
• TABLE 39 North America Others Market by Country, 2019 - 2022, USD Million
• TABLE 40 North America Others Market by Country, 2023 - 2029, USD Million
• TABLE 41 North America Medical Biomimetics Market by Application, 2019 - 2022, USD Million
• TABLE 42 North America Medical Biomimetics Market by Application, 2023 - 2029, USD Million
• TABLE 43 North America Wound Healing Market by Country, 2019 - 2022, USD Million
• TABLE 44 North America Wound Healing Market by Country, 2023 - 2029, USD Million
• TABLE 45 North America Tissue Engineering Market by Country, 2019 - 2022, USD Million
• TABLE 46 North America Tissue Engineering Market by Country, 2023 - 2029, USD Million
• TABLE 47 North America Drug Delivery Market by Country, 2019 - 2022, USD Million
• TABLE 48 North America Drug Delivery Market by Country, 2023 - 2029, USD Million
• TABLE 49 North America Others Market by Country, 2019 - 2022, USD Million
• TABLE 50 North America Others Market by Country, 2023 - 2029, USD Million
• TABLE 51 North America Medical Biomimetics Market by Country, 2019 - 2022, USD Million
• TABLE 52 North America Medical Biomimetics Market by Country, 2023 - 2029, USD Million
• TABLE 53 US Medical Biomimetics Market, 2019 - 2022, USD Million
• TABLE 54 US Medical Biomimetics Market, 2023 - 2029, USD Million
• TABLE 55 US Medical Biomimetics Market by Disease Type, 2019 - 2022, USD Million
• TABLE 56 US Medical Biomimetics Market by Disease Type, 2023 - 2029, USD Million
• TABLE 57 US Medical Biomimetics Market by Application, 2019 - 2022, USD Million
• TABLE 58 US Medical Biomimetics Market by Application, 2023 - 2029, USD Million
• TABLE 59 Canada Medical Biomimetics Market, 2019 - 2022, USD Million
• TABLE 60 Canada Medical Biomimetics Market, 2023 - 2029, USD Million
• TABLE 61 Canada Medical Biomimetics Market by Disease Type, 2019 - 2022, USD Million
• TABLE 62 Canada Medical Biomimetics Market by Disease Type, 2023 - 2029, USD Million
• TABLE 63 Canada Medical Biomimetics Market by Application, 2019 - 2022, USD Million
• TABLE 64 Canada Medical Biomimetics Market by Application, 2023 - 2029, USD Million
• TABLE 65 Mexico Medical Biomimetics Market, 2019 - 2022, USD Million
• TABLE 66 Mexico Medical Biomimetics Market, 2023 - 2029, USD Million
• TABLE 67 Mexico Medical Biomimetics Market by Disease Type, 2019 - 2022, USD Million
• TABLE 68 Mexico Medical Biomimetics Market by Disease Type, 2023 - 2029, USD Million
• TABLE 69 Mexico Medical Biomimetics Market by Application, 2019 - 2022, USD Million
• TABLE 70 Mexico Medical Biomimetics Market by Application, 2023 - 2029, USD Million
• TABLE 71 Rest of North America Medical Biomimetics Market, 2019 - 2022, USD Million
• TABLE 72 Rest of North America Medical Biomimetics Market, 2023 - 2029, USD Million
• TABLE 73 Rest of North America Medical Biomimetics Market by Disease Type, 2019 - 2022, USD Million
• TABLE 74 Rest of North America Medical Biomimetics Market by Disease Type, 2023 - 2029, USD Million
• TABLE 75 Rest of North America Medical Biomimetics Market by Application, 2019 - 2022, USD Million
• TABLE 76 Rest of North America Medical Biomimetics Market by Application, 2023 - 2029, USD Million
• TABLE 77 Europe Medical Biomimetics Market, 2019 - 2022, USD Million
• TABLE 78 Europe Medical Biomimetics Market, 2023 - 2029, USD Million
• TABLE 79 Europe Medical Biomimetics Market by Disease Type, 2019 - 2022, USD Million
• TABLE 80 Europe Medical Biomimetics Market by Disease Type, 2023 - 2029, USD Million
• TABLE 81 Europe Dental Market by Country, 2019 - 2022, USD Million
• TABLE 82 Europe Dental Market by Country, 2023 - 2029, USD Million
• TABLE 83 Europe Orthopedic Market by Country, 2019 - 2022, USD Million
• TABLE 84 Europe Orthopedic Market by Country, 2023 - 2029, USD Million
• TABLE 85 Europe Ophthalmology Market by Country, 2019 - 2022, USD Million
• TABLE 86 Europe Ophthalmology Market by Country, 2023 - 2029, USD Million
• TABLE 87 Europe Cardiovascular Market by Country, 2019 - 2022, USD Million
• TABLE 88 Europe Cardiovascular Market by Country, 2023 - 2029, USD Million
• TABLE 89 Europe Others Market by Country, 2019 - 2022, USD Million
• TABLE 90 Europe Others Market by Country, 2023 - 2029, USD Million
• TABLE 91 Europe Medical Biomimetics Market by Application, 2019 - 2022, USD Million
• TABLE 92 Europe Medical Biomimetics Market by Application, 2023 - 2029, USD Million
• TABLE 93 Europe Wound Healing Market by Country, 2019 - 2022, USD Million
• TABLE 94 Europe Wound Healing Market by Country, 2023 - 2029, USD Million
• TABLE 95 Europe Tissue Engineering Market by Country, 2019 - 2022, USD Million
• TABLE 96 Europe Tissue Engineering Market by Country, 2023 - 2029, USD Million
• TABLE 97 Europe Drug Delivery Market by Country, 2019 - 2022, USD Million
• TABLE 98 Europe Drug Delivery Market by Country, 2023 - 2029, USD Million
• TABLE 99 Europe Others Market by Country, 2019 - 2022, USD Million
• TABLE 100 Europe Others Market by Country, 2023 - 2029, USD Million
• TABLE 101 Europe Medical Biomimetics Market by Country, 2019 - 2022, USD Million
• TABLE 102 Europe Medical Biomimetics Market by Country, 2023 - 2029, USD Million
• TABLE 103 Germany Medical Biomimetics Market, 2019 - 2022, USD Million
• TABLE 104 Germany Medical Biomimetics Market, 2023 - 2029, USD Million
• TABLE 105 Germany Medical Biomimetics Market by Disease Type, 2019 - 2022, USD Million
• TABLE 106 Germany Medical Biomimetics Market by Disease Type, 2023 - 2029, USD Million
• TABLE 107 Germany Medical Biomimetics Market by Application, 2019 - 2022, USD Million
• TABLE 108 Germany Medical Biomimetics Market by Application, 2023 - 2029, USD Million
• TABLE 109 UK Medical Biomimetics Market, 2019 - 2022, USD Million
• TABLE 110 UK Medical Biomimetics Market, 2023 - 2029, USD Million
• TABLE 111 UK Medical Biomimetics Market by Disease Type, 2019 - 2022, USD Million
• TABLE 112 UK Medical Biomimetics Market by Disease Type, 2023 - 2029, USD Million
• TABLE 113 UK Medical Biomimetics Market by Application, 2019 - 2022, USD Million
• TABLE 114 UK Medical Biomimetics Market by Application, 2023 - 2029, USD Million
• TABLE 115 France Medical Biomimetics Market, 2019 - 2022, USD Million
• TABLE 116 France Medical Biomimetics Market, 2023 - 2029, USD Million
• TABLE 117 France Medical Biomimetics Market by Disease Type, 2019 - 2022, USD Million
• TABLE 118 France Medical Biomimetics Market by Disease Type, 2023 - 2029, USD Million
• TABLE 119 France Medical Biomimetics Market by Application, 2019 - 2022, USD Million
• TABLE 120 France Medical Biomimetics Market by Application, 2023 - 2029, USD Million
• TABLE 121 Russia Medical Biomimetics Market, 2019 - 2022, USD Million
• TABLE 122 Russia Medical Biomimetics Market, 2023 - 2029, USD Million
• TABLE 123 Russia Medical Biomimetics Market by Disease Type, 2019 - 2022, USD Million
• TABLE 124 Russia Medical Biomimetics Market by Disease Type, 2023 - 2029, USD Million
• TABLE 125 Russia Medical Biomimetics Market by Application, 2019 - 2022, USD Million
• TABLE 126 Russia Medical Biomimetics Market by Application, 2023 - 2029, USD Million
• TABLE 127 Spain Medical Biomimetics Market, 2019 - 2022, USD Million
• TABLE 128 Spain Medical Biomimetics Market, 2023 - 2029, USD Million
• TABLE 129 Spain Medical Biomimetics Market by Disease Type, 2019 - 2022, USD Million
• TABLE 130 Spain Medical Biomimetics Market by Disease Type, 2023 - 2029, USD Million
• TABLE 131 Spain Medical Biomimetics Market by Application, 2019 - 2022, USD Million
• TABLE 132 Spain Medical Biomimetics Market by Application, 2023 - 2029, USD Million
• TABLE 133 Italy Medical Biomimetics Market, 2019 - 2022, USD Million
• TABLE 134 Italy Medical Biomimetics Market, 2023 - 2029, USD Million
• TABLE 135 Italy Medical Biomimetics Market by Disease Type, 2019 - 2022, USD Million
• TABLE 136 Italy Medical Biomimetics Market by Disease Type, 2023 - 2029, USD Million
• TABLE 137 Italy Medical Biomimetics Market by Application, 2019 - 2022, USD Million
• TABLE 138 Italy Medical Biomimetics Market by Application, 2023 - 2029, USD Million
• TABLE 139 Rest of Europe Medical Biomimetics Market, 2019 - 2022, USD Million
• TABLE 140 Rest of Europe Medical Biomimetics Market, 2023 - 2029, USD Million
• TABLE 141 Rest of Europe Medical Biomimetics Market by Disease Type, 2019 - 2022, USD Million
• TABLE 142 Rest of Europe Medical Biomimetics Market by Disease Type, 2023 - 2029, USD Million
• TABLE 143 Rest of Europe Medical Biomimetics Market by Application, 2019 - 2022, USD Million
• TABLE 144 Rest of Europe Medical Biomimetics Market by Application, 2023 - 2029, USD Million
• TABLE 145 Asia Pacific Medical Biomimetics Market, 2019 - 2022, USD Million
• TABLE 146 Asia Pacific Medical Biomimetics Market, 2023 - 2029, USD Million
• TABLE 147 Asia Pacific Medical Biomimetics Market by Disease Type, 2019 - 2022, USD Million
• TABLE 148 Asia Pacific Medical Biomimetics Market by Disease Type, 2023 - 2029, USD Million
• TABLE 149 Asia Pacific Dental Market by Country, 2019 - 2022, USD Million
• TABLE 150 Asia Pacific Dental Market by Country, 2023 - 2029, USD Million
• TABLE 151 Asia Pacific Orthopedic Market by Country, 2019 - 2022, USD Million
• TABLE 152 Asia Pacific Orthopedic Market by Country, 2023 - 2029, USD Million
• TABLE 153 Asia Pacific Ophthalmology Market by Country, 2019 - 2022, USD Million
• TABLE 154 Asia Pacific Ophthalmology Market by Country, 2023 - 2029, USD Million
• TABLE 155 Asia Pacific Cardiovascular Market by Country, 2019 - 2022, USD Million
• TABLE 156 Asia Pacific Cardiovascular Market by Country, 2023 - 2029, USD Million
• TABLE 157 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
• TABLE 158 Asia Pacific Others Market by Country, 2023 - 2029, USD Million
• TABLE 159 Asia Pacific Medical Biomimetics Market by Application, 2019 - 2022, USD Million
• TABLE 160 Asia Pacific Medical Biomimetics Market by Application, 2023 - 2029, USD Million
• TABLE 161 Asia Pacific Wound Healing Market by Country, 2019 - 2022, USD Million
• TABLE 162 Asia Pacific Wound Healing Market by Country, 2023 - 2029, USD Million
• TABLE 163 Asia Pacific Tissue Engineering Market by Country, 2019 - 2022, USD Million
• TABLE 164 Asia Pacific Tissue Engineering Market by Country, 2023 - 2029, USD Million
• TABLE 165 Asia Pacific Drug Delivery Market by Country, 2019 - 2022, USD Million
• TABLE 166 Asia Pacific Drug Delivery Market by Country, 2023 - 2029, USD Million
• TABLE 167 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
• TABLE 168 Asia Pacific Others Market by Country, 2023 - 2029, USD Million
• TABLE 169 Asia Pacific Medical Biomimetics Market by Country, 2019 - 2022, USD Million
• TABLE 170 Asia Pacific Medical Biomimetics Market by Country, 2023 - 2029, USD Million
• TABLE 171 China Medical Biomimetics Market, 2019 - 2022, USD Million
• TABLE 172 China Medical Biomimetics Market, 2023 - 2029, USD Million
• TABLE 173 China Medical Biomimetics Market by Disease Type, 2019 - 2022, USD Million
• TABLE 174 China Medical Biomimetics Market by Disease Type, 2023 - 2029, USD Million
• TABLE 175 China Medical Biomimetics Market by Application, 2019 - 2022, USD Million
• TABLE 176 China Medical Biomimetics Market by Application, 2023 - 2029, USD Million
• TABLE 177 Japan Medical Biomimetics Market, 2019 - 2022, USD Million
• TABLE 178 Japan Medical Biomimetics Market, 2023 - 2029, USD Million
• TABLE 179 Japan Medical Biomimetics Market by Disease Type, 2019 - 2022, USD Million
• TABLE 180 Japan Medical Biomimetics Market by Disease Type, 2023 - 2029, USD Million
• TABLE 181 Japan Medical Biomimetics Market by Application, 2019 - 2022, USD Million
• TABLE 182 Japan Medical Biomimetics Market by Application, 2023 - 2029, USD Million
• TABLE 183 India Medical Biomimetics Market, 2019 - 2022, USD Million
• TABLE 184 India Medical Biomimetics Market, 2023 - 2029, USD Million
• TABLE 185 India Medical Biomimetics Market by Disease Type, 2019 - 2022, USD Million
• TABLE 186 India Medical Biomimetics Market by Disease Type, 2023 - 2029, USD Million
• TABLE 187 India Medical Biomimetics Market by Application, 2019 - 2022, USD Million
• TABLE 188 India Medical Biomimetics Market by Application, 2023 - 2029, USD Million
• TABLE 189 South Korea Medical Biomimetics Market, 2019 - 2022, USD Million
• TABLE 190 South Korea Medical Biomimetics Market, 2023 - 2029, USD Million
• TABLE 191 South Korea Medical Biomimetics Market by Disease Type, 2019 - 2022, USD Million
• TABLE 192 South Korea Medical Biomimetics Market by Disease Type, 2023 - 2029, USD Million
• TABLE 193 South Korea Medical Biomimetics Market by Application, 2019 - 2022, USD Million
• TABLE 194 South Korea Medical Biomimetics Market by Application, 2023 - 2029, USD Million
• TABLE 195 Singapore Medical Biomimetics Market, 2019 - 2022, USD Million
• TABLE 196 Singapore Medical Biomimetics Market, 2023 - 2029, USD Million
• TABLE 197 Singapore Medical Biomimetics Market by Disease Type, 2019 - 2022, USD Million
• TABLE 198 Singapore Medical Biomimetics Market by Disease Type, 2023 - 2029, USD Million
• TABLE 199 Singapore Medical Biomimetics Market by Application, 2019 - 2022, USD Million
• TABLE 200 Singapore Medical Biomimetics Market by Application, 2023 - 2029, USD Million
• TABLE 201 Malaysia Medical Biomimetics Market, 2019 - 2022, USD Million
• TABLE 202 Malaysia Medical Biomimetics Market, 2023 - 2029, USD Million
• TABLE 203 Malaysia Medical Biomimetics Market by Disease Type, 2019 - 2022, USD Million
• TABLE 204 Malaysia Medical Biomimetics Market by Disease Type, 2023 - 2029, USD Million
• TABLE 205 Malaysia Medical Biomimetics Market by Application, 2019 - 2022, USD Million
• TABLE 206 Malaysia Medical Biomimetics Market by Application, 2023 - 2029, USD Million
• TABLE 207 Rest of Asia Pacific Medical Biomimetics Market, 2019 - 2022, USD Million
• TABLE 208 Rest of Asia Pacific Medical Biomimetics Market, 2023 - 2029, USD Million
• TABLE 209 Rest of Asia Pacific Medical Biomimetics Market by Disease Type, 2019 - 2022, USD Million
• TABLE 210 Rest of Asia Pacific Medical Biomimetics Market by Disease Type, 2023 - 2029, USD Million
• TABLE 211 Rest of Asia Pacific Medical Biomimetics Market by Application, 2019 - 2022, USD Million
• TABLE 212 Rest of Asia Pacific Medical Biomimetics Market by Application, 2023 - 2029, USD Million
• TABLE 213 LAMEA Medical Biomimetics Market, 2019 - 2022, USD Million
• TABLE 214 LAMEA Medical Biomimetics Market, 2023 - 2029, USD Million
• TABLE 215 LAMEA Medical Biomimetics Market by Disease Type, 2019 - 2022, USD Million
• TABLE 216 LAMEA Medical Biomimetics Market by Disease Type, 2023 - 2029, USD Million
• TABLE 217 LAMEA Dental Market by Country, 2019 - 2022, USD Million
• TABLE 218 LAMEA Dental Market by Country, 2023 - 2029, USD Million
• TABLE 219 LAMEA Orthopedic Market by Country, 2019 - 2022, USD Million
• TABLE 220 LAMEA Orthopedic Market by Country, 2023 - 2029, USD Million
• TABLE 221 LAMEA Ophthalmology Market by Country, 2019 - 2022, USD Million
• TABLE 222 LAMEA Ophthalmology Market by Country, 2023 - 2029, USD Million
• TABLE 223 LAMEA Cardiovascular Market by Country, 2019 - 2022, USD Million
• TABLE 224 LAMEA Cardiovascular Market by Country, 2023 - 2029, USD Million
• TABLE 225 LAMEA Others Market by Country, 2019 - 2022, USD Million
• TABLE 226 LAMEA Others Market by Country, 2023 - 2029, USD Million
• TABLE 227 LAMEA Medical Biomimetics Market by Application, 2019 - 2022, USD Million
• TABLE 228 LAMEA Medical Biomimetics Market by Application, 2023 - 2029, USD Million
• TABLE 229 LAMEA Wound Healing Market by Country, 2019 - 2022, USD Million
• TABLE 230 LAMEA Wound Healing Market by Country, 2023 - 2029, USD Million
• TABLE 231 LAMEA Tissue Engineering Market by Country, 2019 - 2022, USD Million
• TABLE 232 LAMEA Tissue Engineering Market by Country, 2023 - 2029, USD Million
• TABLE 233 LAMEA Drug Delivery Market by Country, 2019 - 2022, USD Million
• TABLE 234 LAMEA Drug Delivery Market by Country, 2023 - 2029, USD Million
• TABLE 235 LAMEA Others Market by Country, 2019 - 2022, USD Million
• TABLE 236 LAMEA Others Market by Country, 2023 - 2029, USD Million
• TABLE 237 LAMEA Medical Biomimetics Market by Country, 2019 - 2022, USD Million
• TABLE 238 LAMEA Medical Biomimetics Market by Country, 2023 - 2029, USD Million
• TABLE 239 Brazil Medical Biomimetics Market, 2019 - 2022, USD Million
• TABLE 240 Brazil Medical Biomimetics Market, 2023 - 2029, USD Million
• TABLE 241 Brazil Medical Biomimetics Market by Disease Type, 2019 - 2022, USD Million
• TABLE 242 Brazil Medical Biomimetics Market by Disease Type, 2023 - 2029, USD Million
• TABLE 243 Brazil Medical Biomimetics Market by Application, 2019 - 2022, USD Million
• TABLE 244 Brazil Medical Biomimetics Market by Application, 2023 - 2029, USD Million
• TABLE 245 Argentina Medical Biomimetics Market, 2019 - 2022, USD Million
• TABLE 246 Argentina Medical Biomimetics Market, 2023 - 2029, USD Million
• TABLE 247 Argentina Medical Biomimetics Market by Disease Type, 2019 - 2022, USD Million
• TABLE 248 Argentina Medical Biomimetics Market by Disease Type, 2023 - 2029, USD Million
• TABLE 249 Argentina Medical Biomimetics Market by Application, 2019 - 2022, USD Million
• TABLE 250 Argentina Medical Biomimetics Market by Application, 2023 - 2029, USD Million
• TABLE 251 UAE Medical Biomimetics Market, 2019 - 2022, USD Million
• TABLE 252 UAE Medical Biomimetics Market, 2023 - 2029, USD Million
• TABLE 253 UAE Medical Biomimetics Market by Disease Type, 2019 - 2022, USD Million
• TABLE 254 UAE Medical Biomimetics Market by Disease Type, 2023 - 2029, USD Million
• TABLE 255 UAE Medical Biomimetics Market by Application, 2019 - 2022, USD Million
• TABLE 256 UAE Medical Biomimetics Market by Application, 2023 - 2029, USD Million
• TABLE 257 Saudi Arabia Medical Biomimetics Market, 2019 - 2022, USD Million
• TABLE 258 Saudi Arabia Medical Biomimetics Market, 2023 - 2029, USD Million
• TABLE 259 Saudi Arabia Medical Biomimetics Market by Disease Type, 2019 - 2022, USD Million
• TABLE 260 Saudi Arabia Medical Biomimetics Market by Disease Type, 2023 - 2029, USD Million
• TABLE 261 Saudi Arabia Medical Biomimetics Market by Application, 2019 - 2022, USD Million
• TABLE 262 Saudi Arabia Medical Biomimetics Market by Application, 2023 - 2029, USD Million
• TABLE 263 South Africa Medical Biomimetics Market, 2019 - 2022, USD Million
• TABLE 264 South Africa Medical Biomimetics Market, 2023 - 2029, USD Million
• TABLE 265 South Africa Medical Biomimetics Market by Disease Type, 2019 - 2022, USD Million
• TABLE 266 South Africa Medical Biomimetics Market by Disease Type, 2023 - 2029, USD Million
• TABLE 267 South Africa Medical Biomimetics Market by Application, 2019 - 2022, USD Million
• TABLE 268 South Africa Medical Biomimetics Market by Application, 2023 - 2029, USD Million
• TABLE 269 Nigeria Medical Biomimetics Market, 2019 - 2022, USD Million
• TABLE 270 Nigeria Medical Biomimetics Market, 2023 - 2029, USD Million
• TABLE 271 Nigeria Medical Biomimetics Market by Disease Type, 2019 - 2022, USD Million
• TABLE 272 Nigeria Medical Biomimetics Market by Disease Type, 2023 - 2029, USD Million
• TABLE 273 Nigeria Medical Biomimetics Market by Application, 2019 - 2022, USD Million
• TABLE 274 Nigeria Medical Biomimetics Market by Application, 2023 - 2029, USD Million
• TABLE 275 Rest of LAMEA Medical Biomimetics Market, 2019 - 2022, USD Million
• TABLE 276 Rest of LAMEA Medical Biomimetics Market, 2023 - 2029, USD Million
• TABLE 277 Rest of LAMEA Medical Biomimetics Market by Disease Type, 2019 - 2022, USD Million
• TABLE 278 Rest of LAMEA Medical Biomimetics Market by Disease Type, 2023 - 2029, USD Million
• TABLE 279 Rest of LAMEA Medical Biomimetics Market by Application, 2019 - 2022, USD Million
• TABLE 280 Rest of LAMEA Medical Biomimetics Market by Application, 2023 - 2029, USD Million
• TABLE 281 key Information - Zimmer Biomet Holdings, Inc.
• TABLE 282 Key Information - BioHorizons, Inc.
• TABLE 283 Key Information - SynTouch Inc.
• TABLE 284 Key Information - CorNeat Vision Ltd.
• TABLE 285 Key Information - Osteopore International Pte Ltd
• TABLE 286 Key Information - Curasan, inc.
• TABLE 287 Key Information - Otsuka Medical Devices Co., Ltd.
• TABLE 288 Key Information - Swedish Biomimetics 3000 ApS
• TABLE 289 Key Information - Keystone Dental Group
• TABLE 290 Key Information - Blatchford Limited

List of Figures

• FIG 1 Methodology for the research
• FIG 2 Global Medical Biomimetics Market share by Disease Type, 2022
• FIG 3 Global Medical Biomimetics Market share by Disease Type, 2029
• FIG 4 Global Medical Biomimetics Market by Disease Type, 2019 - 2029, USD Million
• FIG 5 Global Medical Biomimetics Market share by Application, 2022
• FIG 6 Global Medical Biomimetics Market share by Application, 2029
• FIG 7 Global Medical Biomimetics Market by Application, 2019 - 2029, USD Million
• FIG 8 Global Medical Biomimetics Market share by Region, 2022
• FIG 9 Global Medical Biomimetics Market share by Region, 2029
• FIG 10 Global Medical Biomimetics Market by Region, 2019 - 2029, USD Million

The Global Medical Biomimetics Market size is expected to reach $57.7 billion by 2029, rising at a market growth of 6.9% CAGR during the forecast period.

A medical product category, medical biomimetics, was created by taking design cues from natural components. Problems relating to cardiac diseases, orthopedic diseases, ocular diseases, and dental diseases are resolved using medical biomimetics. Drug delivery and tissue regeneration are two medical applications of biomimicry.

In order to use natural systems and organisms as the basis for new scientific, technical, and technological solutions suitable for interventional use in dentistry and medicine, including tissue bio-engineering, biomimicry is a fusion of approaches needing the detection, perception, observation, identification, and close study of these entities.

A similar journey invites elucidating the underlying mechanisms and connections between the function and structure of the stimulating natural system(s) for applied and translational biomimetics, biomimicry, or biomimetics to humans, whether as single individuals or in groups and when healthy end-users/consumers or patients in need of therapies. Biomimetics is a multidisciplinary field that utilizes principles from chemistry, engineering, and biology to create materials, machines, or synthetic systems that mimic biological processes.

Biomimetics-based designs have potential applications in drug delivery, regenerative medicine, and tissue engineering. In addition, utilizing biomimetics in the field of pharmaceutics and medicine shows great potential for addressing life-threatening illnesses such as cancer. The rapid expansion of the medical biomimetics market is primarily fueled by heightened government investment in biomimetics research, as well as the integration and advancements of medical engineering and nanotechnology in the healthcare sector.

COVID-19 Impact Analysis

Companies have restarted their procedures to fulfill the demand for products, as a result of the easing of lockdowns, the advantages of vaccinations, and a drop in COVID-19 cases. Quarantine and the pandemic scenario are getting better and clearly on the mend in many nations. Several practitioners have launched their services by putting local and international guidance into practice. Additionally, the market share for medical biomimetics increased during the forecast period due to increased sales of medical biomimetics, technological advancements in biomimetic products, government initiatives to lessen the burden of disease, and regulatory approval. Therefore, it is anticipated that these trends will stabilize the market and cause it to grow over the course of the forecast period.

Market Growth Factors

The constant aging of the population raises the demand for biomimetics

The growing older population is one of the most important concerns impacting emerging nations globally. It is also projected that the prevalence of chronic conditions in the elderly, such as heart disease, peripheral artery disease, and venous thromboembolism, will increase demand for and adoption of medical biomimetics. According to research by the Centers for Disease Control and Prevention, nearly 27% of men and more than 21% of women will have peripheral vascular disease in 2020, affecting more than 19.1% of people aged 55 to 65. As a result of expanding uses of biomimetics in patient care joined with the increasing number of diseases due to the aging population will aid in the market growth.

Growing nanotechnology development to support the market growth

The advancements in drug delivery systems brought about by nanotechnology innovations will positively affect the growth of medical biomimetics during the forecast period. Nanomaterials are appealing for biomedical applications and show tremendous potential in biomimicry medicine based on their biocompatibility, physical and chemical properties. The development of biomimetic functionalized nanotechnology has allowed for the functionalization and modification of nanomaterials by components obtained from cell membranes, resulting in biomimetic nanomaterials with improved stability, biocompatibility, specificity, and targeting. Thus, using biomimetic nanomaterials for non-invasive disease diagnosis can aid the market growth during the projected period.

Market Restraining Factors

High cost associated with medical biomimetics

The complicated manufacturing procedures needed to create biomimetic technology might make them expensive to develop and produce. This may reduce its accessibility to patients by lowering its pricing and availability. In addition, because it is much more difficult to work with the chemicals needed to make traditional pharmaceuticals and even biopharmaceuticals than working with cells or viral vectors, cell and gene therapies have become much more expensive. As a result, the number of patients who will receive the drug is multiplied by thousands or millions for typical biopharmaceuticals. Thus, the high cost associated with medical biomimetics is anticipated to hamper the market growth during the anticipated period.

Disease Type Outlook

Based on disease type, the medical biomimetics market is characterized into ophthalmology, cardiovascular, orthopedic, dental, and others. The cardiovascular segment procured a considerable growth rate in the medical biomimetics market in 2022. This is because, with 17.9 million deaths annually, CVD is the leading cause of death globally. Every year, more than 2.1 million people have CVD implants to prolong their lives. Additionally, during the forecast period, the segment will benefit from lucrative opportunities brought on by the introduction of technologically advanced products and government funding, which will increase the utilization of medical biomimetics and thereby surge the segment's growth.

Application Outlook

On the basis of application, the medical biomimetics market is classified into wound healing, tissue engineering, drug delivery, and others. The wound healing segment witnessed the largest revenue share in the medical biomimetics market in 2022. This is owing to a growing number of surgical cases and the rise in the incidence of chronic diseases, increasing the demand for products promoting wound healing and wound care. It is becoming increasingly advantageous to reroute fibrotic wound healing toward a regeneration process by advancing instructional materials and biomimetics.

Regional Outlook

Region wise, the medical biomimetics market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region generate the highest revenue share in the medical biomimetics market in 2022. This is due to increased dental disorders that necessitate dental biomimetics goods, increased government support for biomimetics product research, and a considerable increase in capital income in industrialized countries. In addition, the sophisticated reimbursement mechanism that already exists and strives to lower expenditure levels also contributes to the market's expansion. As a result, these elements fuel the medical biomimetics market growth in the North America region.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Zimmer Biomet Holdings, Inc., BioHorizons, Inc. (Henry Schein, Inc.), SynTouch Inc., CorNeat Vision Ltd., Osteopore International Pte Ltd, Curasan, Inc., Otsuka Medical Devices Co., Ltd. (Otsuka Holdings Co. Ltd.), Swedish Biomimetics 3000 ApS, Keystone Dental Group and Blatchford Limited.

Strategies Deployed in Medical Biomimetics Market

Oct-2022: CorNeat has launched EverMatrix tissue integrating material technology. Evermatrix features a 100% synthetic biomimetic extracellular matrix that merges with human tissue for a lifetime. It also features a flexible and tough body structure that maintains its form when drenched.

Jul-2022: Curasan AG launched CERASORB CPC bone fillers.CERASORB CPC features phosphate and calcium salts dispersed in biocompatible oil made from plant extracts. The product is used mainly for minimally invasive applications. By introducing this product, curasan AG has strengthened its position in the market by countering the problems faced by medical personnel due to following a rigid protocol during the treatment of the wound.

Apr-2022: Keystone Dental Group has teamed up with Milestone Scientific for a channel partnership regarding Milestone's STA Single Tooth Anesthesia System. The collaboration aims at providing better patient care for Keystone's customers.

Sep-2021: Keystone Dental Inc. took over Osteon Medical. The acquisition strengthens Keystone's position in the dental market and provides sales opportunities for its synergistic and expanded implants. Furthermore, Keystone would be able to serve its customers in a better way owing to the combined portfolio of the company after the acquisition.

Mar-2021: CorNeat has partnered with LiveU, a remote solution production and video streaming company, for developing Remote Surgeon Virtual Presence (RSVP) Solution. The new solution would allow CorNeat to spread its clinical trials to more sites. RSVP also serves as a compliment for launching Corneat Kpro to train surgeons virtually across the globe.

Jan-2021: Osteopore International has teamed up with Maastricht University Medical Centre to develop a bone implant solution that averts leg amputation. This collaboration is directed at the adoption of 3D-printed bioresorbable implants across a wide clinical base.

Aug-2020: Blatchford Limited has unveiled ElanIC, a firm, and lightweight microprocessor-enabled hydraulic ankle. ElanIC features a lightweight and compact waterproof design that provides greater comfort to the user. Furthermore, the prosthetic features a standing support mode to improve the resistance when the user is stationary. The benefits of the prosthetic include reduced risk of trips, increased walking speed, improved ground clearance, and enhanced control.

Scope of the Study

Market Segments covered in the Report:

By Disease Type

• Dental
• Orthopedic
• Ophthalmology
• Cardiovascular
• Others

By Application

• Wound Healing
• Tissue Engineering
• Drug Delivery
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Zimmer Biomet Holdings, Inc.
• BioHorizons, Inc. (Henry Schein, Inc.)
• SynTouch Inc.
• CorNeat Vision Ltd.
• Osteopore International Pte Ltd
• Curasan, Inc.
• Otsuka Medical Devices Co., Ltd. (Otsuka Holdings Co. Ltd.)
• Swedish Biomimetics 3000 ApS
• Keystone Dental Group
• Blatchford Limited

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Medical Biomimetics Market, by Disease Type
  • 1.4.2 Global Medical Biomimetics Market, by Application
  • 1.4.3 Global Medical Biomimetics Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market Overview

• 2.1 Introduction
  • 2.1.1 Overview
    • 2.1.1.1 Market Composition & Scenario
• 2.2 Key Factors Impacting the Market
  • 2.2.1 Market Drivers
  • 2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Medical Biomimetics Market

Chapter 4. Global Medical Biomimetics Market by Disease Type

• 4.1 Global Dental Market by Region
• 4.2 Global Orthopedic Market by Region
• 4.3 Global Ophthalmology Market by Region
• 4.4 Global Cardiovascular Market by Region
• 4.5 Global Others Market by Region

Chapter 5. Global Medical Biomimetics Market by Application

• 5.1 Global Wound Healing Market by Region
• 5.2 Global Tissue Engineering Market by Region
• 5.3 Global Drug Delivery Market by Region
• 5.4 Global Others Market by Region

Chapter 6. Global Medical Biomimetics Market by Region

• 6.1 North America Medical Biomimetics Market
  • 6.1.1 North America Medical Biomimetics Market by Disease Type
    • 6.1.1.1 North America Dental Market by Country
    • 6.1.1.2 North America Orthopedic Market by Country
    • 6.1.1.3 North America Ophthalmology Market by Country
    • 6.1.1.4 North America Cardiovascular Market by Country
    • 6.1.1.5 North America Others Market by Country
  • 6.1.2 North America Medical Biomimetics Market by Application
    • 6.1.2.1 North America Wound Healing Market by Country
    • 6.1.2.2 North America Tissue Engineering Market by Country
    • 6.1.2.3 North America Drug Delivery Market by Country
    • 6.1.2.4 North America Others Market by Country
  • 6.1.3 North America Medical Biomimetics Market by Country
    • 6.1.3.1 US Medical Biomimetics Market
      • 6.1.3.1.1 US Medical Biomimetics Market by Disease Type
      • 6.1.3.1.2 US Medical Biomimetics Market by Application
    • 6.1.3.2 Canada Medical Biomimetics Market
      • 6.1.3.2.1 Canada Medical Biomimetics Market by Disease Type
      • 6.1.3.2.2 Canada Medical Biomimetics Market by Application
    • 6.1.3.3 Mexico Medical Biomimetics Market
      • 6.1.3.3.1 Mexico Medical Biomimetics Market by Disease Type
      • 6.1.3.3.2 Mexico Medical Biomimetics Market by Application
    • 6.1.3.4 Rest of North America Medical Biomimetics Market
      • 6.1.3.4.1 Rest of North America Medical Biomimetics Market by Disease Type
      • 6.1.3.4.2 Rest of North America Medical Biomimetics Market by Application
• 6.2 Europe Medical Biomimetics Market
  • 6.2.1 Europe Medical Biomimetics Market by Disease Type
    • 6.2.1.1 Europe Dental Market by Country
    • 6.2.1.2 Europe Orthopedic Market by Country
    • 6.2.1.3 Europe Ophthalmology Market by Country
    • 6.2.1.4 Europe Cardiovascular Market by Country
    • 6.2.1.5 Europe Others Market by Country
  • 6.2.2 Europe Medical Biomimetics Market by Application
    • 6.2.2.1 Europe Wound Healing Market by Country
    • 6.2.2.2 Europe Tissue Engineering Market by Country
    • 6.2.2.3 Europe Drug Delivery Market by Country
    • 6.2.2.4 Europe Others Market by Country
  • 6.2.3 Europe Medical Biomimetics Market by Country
    • 6.2.3.1 Germany Medical Biomimetics Market
      • 6.2.3.1.1 Germany Medical Biomimetics Market by Disease Type
      • 6.2.3.1.2 Germany Medical Biomimetics Market by Application
    • 6.2.3.2 UK Medical Biomimetics Market
      • 6.2.3.2.1 UK Medical Biomimetics Market by Disease Type
      • 6.2.3.2.2 UK Medical Biomimetics Market by Application
    • 6.2.3.3 France Medical Biomimetics Market
      • 6.2.3.3.1 France Medical Biomimetics Market by Disease Type
      • 6.2.3.3.2 France Medical Biomimetics Market by Application
    • 6.2.3.4 Russia Medical Biomimetics Market
      • 6.2.3.4.1 Russia Medical Biomimetics Market by Disease Type
      • 6.2.3.4.2 Russia Medical Biomimetics Market by Application
    • 6.2.3.5 Spain Medical Biomimetics Market
      • 6.2.3.5.1 Spain Medical Biomimetics Market by Disease Type
      • 6.2.3.5.2 Spain Medical Biomimetics Market by Application
    • 6.2.3.6 Italy Medical Biomimetics Market
      • 6.2.3.6.1 Italy Medical Biomimetics Market by Disease Type
      • 6.2.3.6.2 Italy Medical Biomimetics Market by Application
    • 6.2.3.7 Rest of Europe Medical Biomimetics Market
      • 6.2.3.7.1 Rest of Europe Medical Biomimetics Market by Disease Type
      • 6.2.3.7.2 Rest of Europe Medical Biomimetics Market by Application
• 6.3 Asia Pacific Medical Biomimetics Market
  • 6.3.1 Asia Pacific Medical Biomimetics Market by Disease Type
    • 6.3.1.1 Asia Pacific Dental Market by Country
    • 6.3.1.2 Asia Pacific Orthopedic Market by Country
    • 6.3.1.3 Asia Pacific Ophthalmology Market by Country
    • 6.3.1.4 Asia Pacific Cardiovascular Market by Country
    • 6.3.1.5 Asia Pacific Others Market by Country
  • 6.3.2 Asia Pacific Medical Biomimetics Market by Application
    • 6.3.2.1 Asia Pacific Wound Healing Market by Country
    • 6.3.2.2 Asia Pacific Tissue Engineering Market by Country
    • 6.3.2.3 Asia Pacific Drug Delivery Market by Country
    • 6.3.2.4 Asia Pacific Others Market by Country
  • 6.3.3 Asia Pacific Medical Biomimetics Market by Country
    • 6.3.3.1 China Medical Biomimetics Market
      • 6.3.3.1.1 China Medical Biomimetics Market by Disease Type
      • 6.3.3.1.2 China Medical Biomimetics Market by Application
    • 6.3.3.2 Japan Medical Biomimetics Market
      • 6.3.3.2.1 Japan Medical Biomimetics Market by Disease Type
      • 6.3.3.2.2 Japan Medical Biomimetics Market by Application
    • 6.3.3.3 India Medical Biomimetics Market
      • 6.3.3.3.1 India Medical Biomimetics Market by Disease Type
      • 6.3.3.3.2 India Medical Biomimetics Market by Application
    • 6.3.3.4 South Korea Medical Biomimetics Market
      • 6.3.3.4.1 South Korea Medical Biomimetics Market by Disease Type
      • 6.3.3.4.2 South Korea Medical Biomimetics Market by Application
    • 6.3.3.5 Singapore Medical Biomimetics Market
      • 6.3.3.5.1 Singapore Medical Biomimetics Market by Disease Type
      • 6.3.3.5.2 Singapore Medical Biomimetics Market by Application
    • 6.3.3.6 Malaysia Medical Biomimetics Market
      • 6.3.3.6.1 Malaysia Medical Biomimetics Market by Disease Type
      • 6.3.3.6.2 Malaysia Medical Biomimetics Market by Application
    • 6.3.3.7 Rest of Asia Pacific Medical Biomimetics Market
      • 6.3.3.7.1 Rest of Asia Pacific Medical Biomimetics Market by Disease Type
      • 6.3.3.7.2 Rest of Asia Pacific Medical Biomimetics Market by Application
• 6.4 LAMEA Medical Biomimetics Market
  • 6.4.1 LAMEA Medical Biomimetics Market by Disease Type
    • 6.4.1.1 LAMEA Dental Market by Country
    • 6.4.1.2 LAMEA Orthopedic Market by Country
    • 6.4.1.3 LAMEA Ophthalmology Market by Country
    • 6.4.1.4 LAMEA Cardiovascular Market by Country
    • 6.4.1.5 LAMEA Others Market by Country
  • 6.4.2 LAMEA Medical Biomimetics Market by Application
    • 6.4.2.1 LAMEA Wound Healing Market by Country
    • 6.4.2.2 LAMEA Tissue Engineering Market by Country
    • 6.4.2.3 LAMEA Drug Delivery Market by Country
    • 6.4.2.4 LAMEA Others Market by Country
  • 6.4.3 LAMEA Medical Biomimetics Market by Country
    • 6.4.3.1 Brazil Medical Biomimetics Market
      • 6.4.3.1.1 Brazil Medical Biomimetics Market by Disease Type
      • 6.4.3.1.2 Brazil Medical Biomimetics Market by Application
    • 6.4.3.2 Argentina Medical Biomimetics Market
      • 6.4.3.2.1 Argentina Medical Biomimetics Market by Disease Type
      • 6.4.3.2.2 Argentina Medical Biomimetics Market by Application
    • 6.4.3.3 UAE Medical Biomimetics Market
      • 6.4.3.3.1 UAE Medical Biomimetics Market by Disease Type
      • 6.4.3.3.2 UAE Medical Biomimetics Market by Application
    • 6.4.3.4 Saudi Arabia Medical Biomimetics Market
      • 6.4.3.4.1 Saudi Arabia Medical Biomimetics Market by Disease Type
      • 6.4.3.4.2 Saudi Arabia Medical Biomimetics Market by Application
    • 6.4.3.5 South Africa Medical Biomimetics Market
      • 6.4.3.5.1 South Africa Medical Biomimetics Market by Disease Type
      • 6.4.3.5.2 South Africa Medical Biomimetics Market by Application
    • 6.4.3.6 Nigeria Medical Biomimetics Market
      • 6.4.3.6.1 Nigeria Medical Biomimetics Market by Disease Type
      • 6.4.3.6.2 Nigeria Medical Biomimetics Market by Application
    • 6.4.3.7 Rest of LAMEA Medical Biomimetics Market
      • 6.4.3.7.1 Rest of LAMEA Medical Biomimetics Market by Disease Type
      • 6.4.3.7.2 Rest of LAMEA Medical Biomimetics Market by Application

Chapter 7. Company Profiles

• 7.1 Zimmer Biomet Holdings, Inc.
  • 7.1.1 Company Overview
  • 7.1.2 Financial Analysis
  • 7.1.3 Regional Analysis
  • 7.1.4 Research & Development Expense
• 7.2 BioHorizons, Inc. (Henry Schein, Inc.)
  • 7.2.1 Company Overview
  • 7.2.2 Financial Analysis
  • 7.2.3 Segmental and Regional Analysis
• 7.3 SynTouch Inc.
  • 7.3.1 Company Overview
• 7.4 CorNeat Vision Ltd.
  • 7.4.1 Company Overview
  • 7.4.2 Recent strategies and developments:
    • 7.4.2.1 Partnerships, Collaborations, and Agreements:
    • 7.4.2.2 Product Launches and Product Expansions:
• 7.5 Osteopore International Pte Ltd
  • 7.5.1 Company Overview
  • 7.5.2 Recent strategies and developments:
    • 7.5.2.1 Partnerships, Collaborations, and Agreements:
• 7.6 Curasan, Inc.
  • 7.6.1 Company Overview
• 7.7 Otsuka Medical Devices Co., Ltd. (Otsuka Holdings Co. Ltd.)
  • 7.7.1 Company Overview
  • 7.7.2 Financial Analysis
  • 7.7.3 Segmental & Regional Analysis
  • 7.7.4 Research & Development Expense
• 7.8 Swedish Biomimetics 3000 ApS
  • 7.8.1 Company Overview
• 7.9 Keystone Dental Group
  • 7.9.1 Company Overview
  • 7.9.2 Recent strategies and developments:
    • 7.9.2.1 Partnerships, Collaborations, and Agreements:
    • 7.9.2.2 Acquisition and Mergers:
• 7.10. Blatchford Limited
  • 7.10.1 Company Overview
  • 7.10.2 Recent strategies and developments:
    • 7.10.2.1 Partnerships, Collaborations, and Agreements: